Company Overview and News

0
HUL slips 3% despite a better Q1 show; brokerages downgrade rating but raise target price

3h moneycontrol
Shares of Hindustan Unilever slipped more than 3 percent intraday Tuesday despite company reporting better numbers in the quarter ended June 2018. The share has touched a 52-week high of Rs 1,779.95 during the opening trade. The company had reported a 19.2 percent YoY rise in its standalone net profit to Rs 1,529 crore for the quarter ended June.
MS.PRI MS.PRK MS.PRE 500696 MS.PRF HINDUNILVR MS.PRG MS MS.PRA

5
Asia stocks mixed as Japan outperforms on yen drop

3h bworldonline
Asian equities were mixed Tuesday as investors assess whether corporate earnings can deliver on high expectations against a backdrop of trade tensions. Treasuries and the dollar were steady ahead of testimony from Federal Reserve Chairman Jerome Powell.
GS.PRB MS.PRE GS.PRA MS.PRF NFLX MS.PRG MS.PRA GS GLSSP MS JBK GSC GS.PRICL TFG GSJ GS.PRJ GS.PRI BLK MS.PRI GS.PRD MS.PRK GS.PRC GJS GS.PRN GS.PRK

0
HUL posts biggest intraday fall in 11 weeks

3h thehindubusinessline
Shares of consumer goods maker Hindustan Unilever Ltd fell as much as 2.9 per cent to Rs 1,701 rupees, in its biggest intraday percentage fall since May 2, as the company’s net profit missed street estimates.
MS.PRI MS.PRK MS.PRE 500696 MS.PRF HINDUNILVR MS.PRG MS MS.PRA

9
Not even a strong earnings season will break stocks out of their range, Morgan Stanley says - MarketWatch

7h marketwatch
The second-quarter earnings season just started in the U.S., and while the initial reads have shown strong growth for both profits and revenue, such results may not be enough to power the market out of the range it has been stuck in for months.
WFCNP C.WSA MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA WFC.PRT C.WS.B WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN C.WS.A C.PRP C.PRU WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV C.PRS WFC WFC.WS C C.PRL C.PRJ C.PRK C.PRG C.PRC MS.PRI C.PRPCL MS.PRK CGBBW

5
Asian stocks open mixed with US Treasuries, dollar steady

7h malaymail
TOKYO, July 17 — Asian equities opened mixed as investors evaluated whether earnings can deliver on high expectations against a backdrop of trade tensions. Treasuries and the US dollar were steady ahead of testimony from Federal Reserve Chairman Jerome Powell.
JBK GSC GS.PRICL TFG GS.PRB MS.PRE GS.PRA MS.PRF NFLX MS.PRG MS.PRA GSJ GS.PRJ GS.PRI GS GLSSP MS.PRI GS.PRD MS.PRK GS.PRC MS GJS GS.PRN GS.PRK

0
China Hedge Fund Doubles Down as Market Selloff Deepens Losses - Bloomberg

9h bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

1
5 Geopolitical Factors Which Have Affected Oil Prices in 2018

10h zacks
This year, oil prices have been spiking and hitting prices which have not been seen since 2014. However, thanks to more recent news, the continuous rally finally seems to have come to a slow halt.
APA MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA SU SU

0
The Best And Worst Oil Price Predictions

10h oilprice
Julianne Geiger is a veteran editor, writer and researcher for US-based Divergente LLC consulting firm, and a member of the Creative Professionals Networking Group.
MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

1
Netflix (NFLX) Q2 Subscriber Figures Were Alarmingly Low

10h zacks
Netflix (NFLX - Free Report) saw its stock price climb over 1% during regular trading hours Monday in a sign that investors were expecting strong Q2 results from the streaming TV giant. But shares of NFLX plummeted after Netflix failed to meet its own subscriber growth estimates by a wide margin in an announcement that is truly worrisome.
MS.PRI MS.PRK AAPL MS.PRE MS.PRF NFLX MS.PRG MS MS.PRA

4
Bank of America CEO: Mobile banking strength not just from millennials

11h cnbc
Millennials aren't the defining factor in Bank of America's mobile banking strength, which grew by 11 percent in the second quarter to 25.3 million active users, Chairman and CEO Brian Moynihan told CNBC on Monday.
WFC WFCNP WFC.WS MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA WFC.PRT WFC.PRR WFC.PRQ MS.PRI WFC.PRP WFC.PRO WFC.PRN MS.PRK WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV

0
The Growth of Robinhood and What It Means for Brokerage Stocks

11h zacks
E*trade (ETFC - Free Report) and TD Ameritrade (AMTD - Free Report) are household names in the finance space which investors are likely familiar with. Both are online brokerage firms that have been industry leaders for a long time, initially going public in the mid-90s. However, there is a new upstart challenger in town, called Robinhood, which E*trade and TD Ameritrade may have to watch out for.
MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

0
Netflix (NFLX) Slumps on Weaker-Than-Expected Subscriber Growth & Guidance

11h zacks
Netflix, Inc. (NFLX - Free Report) just released its latest quarterly financial results, posting adjusted earnings of 85 cents per share and revenues of $3.91 billion.
MS.PRI MS.PRK MS.PRE MS.PRF NFLX MS.PRG MS MS.PRA

55
How Will Goldman Sachs (GS) and Morgan Stanley (MS) Perform After Big Banks Earnings?

12h zacks
Earnings season is now in full session after JP Morgan (JPM - Free Report) and Citigroup (C - Free Report) beat earnings on Friday while Wells Fargo (WFC - Free Report) stumbled. Bank of America (BAC - Free Report) and Blackstone (BLK - Free Report) were the headliners on Monday, both surpassing expectations and boosting investor confidence.
WFCNP MS.PRE WFC.PRL MS.PRF WFC.PRJ MS.PRG MS.PRA BAC WFC.PRT WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN MS WFC.PRY WFC.PRX WFC.PRW WFC.PRV WFC WFC.WS BAC C MS.PRI MS.PRK

4
Banks soar as earnings flood in, and some see more gains to come

13h cnbc
Financials surged on Monday following strong Bank of America earnings, with peers such as Citigroup, Wells Fargo and Goldman Sachs rallying on the day. As investors navigate the onslaught of big bank reports and volatility in the financial sector, some market watchers are anticipating further upside ahead.
WFC WFCNP WFC.WS MS.PRE WFC.PRL DTK MS.PRF WFC.PRJ MS.PRG MS.PRA WFC.PRT WFC.PRR WFC.PRQ MS.PRI WFC.PRP WFC.PRO WFC.PRN MS.PRK WFC.PRY MS WFC.PRX WFC.PRW WFC.PRV

0
Tenable Holdings Gears Up for IPO

16h 247wallst
Tenable Holdings has registered an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to sell its 9.2 million shares in the range of $17 to $19 a piece, with an overallotment option for an additional 1.38 million shares. At the maximum price, the entire offering is valued up to $201.02 million. The company intends to list its shares on the Nasdaq under the symbol TENB.
DB MS.PRI MS.PRK MS.PRE MS.PRF MS.PRG MS MS.PRA

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

4h - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

5h - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

CUSIP: 61762V200